Loading clinical trials...
Loading clinical trials...
This observational prospective study evaluates the safety, tolerability and efficacy of a probiotic formula in infants with functional gastrointestinal disorders (FGDI)
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AB Biotics, SA
NCT05212129 · Functional Gastrointestinal Disorders, Hypermobile Ehlers-Danlos Syndrome, and more
NCT05880199 · Gastrointestinal Motility Disorders in Children, Functional Gastrointestinal Disorders, and more
NCT07091084 · Constipation, Cancer, and more
NCT03823742 · Irritable Bowel Syndrome, Functional Abdominal Pain Syndrome, and more
NCT06309199 · Functional Gastrointestinal Disorders, Infant Conditions
Azienda Sanitaria Locale Napoli
Naples
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions